Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting
- PMID: 11588148
- DOI: 10.1210/edrv.22.5.0439
Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting
Abstract
The heterotrimeric G protein G(s) couples hormone receptors (as well as other receptors) to the effector enzyme adenylyl cyclase and is therefore required for hormone-stimulated intracellular cAMP generation. Receptors activate G(s) by promoting exchange of GTP for GDP on the G(s) alpha-subunit (G(s)alpha) while an intrinsic GTPase activity of G(s)alpha that hydrolyzes bound GTP to GDP leads to deactivation. Mutations of specific G(s)alpha residues (Arg(201) or Gln(227)) that are critical for the GTPase reaction lead to constitutive activation of G(s)-coupled signaling pathways, and such somatic mutations are found in endocrine tumors, fibrous dysplasia of bone, and the McCune-Albright syndrome. Conversely, heterozygous loss-of-function mutations may lead to Albright hereditary osteodystrophy (AHO), a disease characterized by short stature, obesity, brachydactyly, sc ossifications, and mental deficits. Similar mutations are also associated with progressive osseous heteroplasia. Interestingly, paternal transmission of GNAS1 mutations leads to the AHO phenotype alone (pseudopseudohypoparathyroidism), while maternal transmission leads to AHO plus resistance to several hormones (e.g., PTH, TSH) that activate G(s) in their target tissues (pseudohypoparathyroidism type IA). Studies in G(s)alpha knockout mice demonstrate that G(s)alpha is imprinted in a tissue-specific manner, being expressed primarily from the maternal allele in some tissues (e.g., renal proximal tubule, the major site of renal PTH action), while being biallelically expressed in most other tissues. Disrupting mutations in the maternal allele lead to loss of G(s)alpha expression in proximal tubules and therefore loss of PTH action in the kidney, while mutations in the paternal allele have little effect on G(s)alpha expression or PTH action. G(s)alpha has recently been shown to be also imprinted in human pituitary glands. The G(s)alpha gene GNAS1 (as well as its murine ortholog Gnas) has at least four alternative promoters and first exons, leading to the production of alternative gene products including G(s)alpha, XLalphas (a novel G(s)alpha isoform that is expressed only from the paternal allele), and NESP55 (a chromogranin-like protein that is expressed only from the maternal allele). A fourth alternative promoter and first exon (exon 1A) located approximately 2.5 kb upstream of the G(s)alpha promoter is normally methylated on the maternal allele and transcriptionally active on the paternal allele. In patients with isolated renal resistance to PTH (pseudohypoparathyroidism type IB), the exon 1A promoter region has a paternal-specific imprinting pattern on both alleles (unmethylated, transcriptionally active), suggesting that this region is critical for the tissue-specific imprinting of G(s)alpha. The GNAS1 imprinting defect in pseudohypoparathyroidism type IB is predicted to decrease G(s)alpha expression in renal proximal tubules. Studies in G(s)alpha knockout mice also demonstrate that this gene is critical in the regulation of lipid and glucose metabolism.
Similar articles
-
Gs(alpha) mutations and imprinting defects in human disease.Ann N Y Acad Sci. 2002 Jun;968:173-97. doi: 10.1111/j.1749-6632.2002.tb04335.x. Ann N Y Acad Sci. 2002. PMID: 12119276 Review.
-
Minireview: GNAS: normal and abnormal functions.Endocrinology. 2004 Dec;145(12):5459-64. doi: 10.1210/en.2004-0865. Epub 2004 Aug 26. Endocrinology. 2004. PMID: 15331575 Review.
-
A GNAS1 imprinting defect in pseudohypoparathyroidism type IB.J Clin Invest. 2000 Nov;106(9):1167-74. doi: 10.1172/JCI10431. J Clin Invest. 2000. PMID: 11067869 Free PMC article.
-
The GNAS locus and pseudohypoparathyroidism.Adv Exp Med Biol. 2008;626:27-40. doi: 10.1007/978-0-387-77576-0_3. Adv Exp Med Biol. 2008. PMID: 18372789 Review.
-
[Paternal GNAS mutations: Which phenotypes? What genetic counseling?].Ann Endocrinol (Paris). 2015 May;76(2):105-9. doi: 10.1016/j.ando.2015.03.010. Epub 2015 May 4. Ann Endocrinol (Paris). 2015. PMID: 25952723 Review. French.
Cited by
-
Pseudohypoparathyroidism Type 1A with Normocalcaemia, due to the Novel C.389A>G Variant of Exon 5 of the Guanine Nucleotide-Binding Protein, α-Stimulating Gene.J Bone Metab. 2021 Feb;28(1):85-89. doi: 10.11005/jbm.2021.28.1.85. Epub 2021 Feb 28. J Bone Metab. 2021. PMID: 33730787 Free PMC article.
-
GNAS is not involved in gastrointestinal tumour formation in Peutz-Jeghers syndrome.Fam Cancer. 2013 Sep;12(3):581-2. doi: 10.1007/s10689-013-9602-6. Fam Cancer. 2013. PMID: 23337932
-
Progressive osseous heteroplasia: diagnosis, treatment, and prognosis.Appl Clin Genet. 2015 Jan 30;8:37-48. doi: 10.2147/TACG.S51064. eCollection 2015. Appl Clin Genet. 2015. PMID: 25674011 Free PMC article. Review.
-
A novel polymorphism at the GNAS1 gene associated with low circulating calcium levels.Clin Cases Miner Bone Metab. 2007 May;4(2):139-45. Clin Cases Miner Bone Metab. 2007. PMID: 22461214 Free PMC article.
-
Association of GNAS imprinting defects and deletions of chromosome 2 in two patients: clues explaining phenotypic heterogeneity in pseudohypoparathyroidism type 1B/iPPSD3.Clin Epigenetics. 2019 Jan 7;11(1):3. doi: 10.1186/s13148-018-0607-8. Clin Epigenetics. 2019. PMID: 30616679 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical